Real-time enrollment status for this ret-altered cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT05443126 |
| Recruiting Status | Recruiting |
| Condition | RET-altered Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 265 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Ellipses Pharma |
| Last Updated on CT.gov | February 3, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT05443126 is currently recruiting participants. This clinical trial study for ret-altered cancer is actively seeking new participants at 18 locations across the United States. The study is sponsored by Ellipses Pharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05443126 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05443126 was last updated 3 weeks ago (February 3, 2026). HelloStudys verifies this status automatically.